Press Release FeedGet the RSS feed
Menu

GlobeNewswire

Net Asset Value(s)

GlobeNewswire

October 09, 2026 11:09 ET  | Source: Hargreave Hale AIM VCT plc

9 October 2026

HARGREAVE HALE AIM VCT PLC
(the “Company”)

NAV announcement

As at close of business on 30 September 2026, the unaudited Net Asset Value (NAV) for Hargreave Hale AIM VCT plc was as follows:

NAV per Ordinary share of 1p – 31.80 pence.

END

For further information, please contact:

Canaccord Genuity Asset Management Limited
Abbe Martineau		[email protected]
+44 20 7523 4525
 

LEI: 213800LRYA19A69SIT31        

  1. ESFI Shares Electrical Safety Considerations For Severe StormsSevere Storms Pose Unique Electrical Hazards to Both Homes and Businesses
  2. FinanceFort Technology Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price RequirementFort Technology Inc. (Nasdaq: FRTT, TSXV: FORT) (“Fort” or the “Company”), today announced that on October 13, 2026, it received a written notification (the “Notification”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company is not in compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2).
  3. FinanceDime Commercial Bancshares, Inc.Dime Commercial Bancshares to Release Earnings on October 20, 2026Dime Commercial Bancshares to Release Earnings on October 20, 2026
  4. FinanceKingstone CompaniesKingstone Schedules Third Quarter 2026 Earnings Release and Conference CallKingstone Companies, Inc. (Nasdaq: KINS) ("Kingstone" or the "Company"), a regional property and casualty insurance holding company, today announced that it will issue financial results for the third quarter ended September 30, 2026, after the market closes on Thursday, November 5, 2026.
  5. FinanceZenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative therapies for patients living with autoimmune and inflammatory diseases, today announced that on October 15, 2026 (the “Grant Date”), the Compensation Committee of the Company’s Board of Directors granted an aggregate of 74,900 restricted stock units of the Company’s common stock (“RSUs”) to newly hired employees of the Company as an inducement material to such employees’ entry into employment with the Company, in accordance with Nasdaq Listing Rule 5635(c)(4) (the “Inducement Grant”).
  6. Picton Mahoney Asset ManagementPicton Mahoney Asset Management Announces Monthly Distribution for PICTON Long Short Income Alternative Fund Exchange Traded Fund Units, PICTON Credit Opportunities Alternative Fund Exchange Traded Fund Units, PICTON Core Bond Fund Exchange Traded Fund Units, PICTON Multi-Strategy Alpha Alternative Fund Exchange Traded Fund Units and PICTON Investment Grade Alternative Fund Exchange Traded Fund Units(TSX: PFIA, PFCO, PFCB, PFAA, PFIG) Picton Mahoney Asset Management (“PICTON Investments”) announced today that it has declared the October 2026 monthly cash distribution of $0.0587 per unit for the ETF units (“ETF Units”) of the PICTON Long Short Income Alternative Fund.